Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704834 · ClinicalTrials.gov registry record
Gene Expression Profiles in Multiple Sclerosis (MS)
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 46
- Enrollment target
NCT00704834 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 46 participants.
The verdict
NCT00704834 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to test differences in RNA levels between Multiple Sclerosis (MS) patients and normal subjects. RNA provides a "message" from genes altered in diseases. We will also test DNA to determine if there are any small mutations called SNPs in any of the genes. The last tests are two separate tests for markers of inflammation called cytokines and eicosanoids. This research may lead to the discovery of biological markers for MS that are useful for diagnosis and treatment.
Interventions
- OTHER Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2006-03 |
| Est. Completion | 2017-07-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00704834
The ClinicalTrials.gov registry entry for NCT00704834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT00704834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00704834 about?
NCT00704834 is a clinical study titled "Gene Expression Profiles in Multiple Sclerosis (MS)". The purpose of this study is to test differences in RNA levels between Multiple Sclerosis (MS) patients and normal subjects. RNA provides a "message" from genes altered in diseases. We will also test DNA to determine if there are any small mutations called SNPs in any of the genes. The last tests ar...
What is the current status of trial NCT00704834?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2006-03. Estimated completion is 2017-07-05.
What interventions are being tested in trial NCT00704834?
The interventions under investigation include: Blood Draw (OTHER).
Who is sponsoring clinical trial NCT00704834?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.